Journal of International Oncology››2015,Vol. 42››Issue (1): 49-51.doi:10.3760/cma.j.issn.1673-422X.2015.01.013
Previous ArticlesNext Articles
Ge Yizhi, Wang Buhai, Xu Lichun
Received:
2014-06-10Revised:
2014-08-04Online:
2015-01-08Published:
2015-01-07Contact:
Xu Lichun E-mail:732718420@qq.comGe Yizhi, Wang Buhai, Xu Lichun. Radiotherapy sensitization mechanisms of tumor necrosis factor-α[J]. Journal of International Oncology, 2015, 42(1): 49-51.
[1] Jones GR, Kennedy NA, Lees CW, et al. Systematic review: the use of thiopurines or antiTNF in postoperative Crohn′s disease maintenance_progress and prospects[J]. Aliment Pharmacol Ther, 2014, 39(11): 1253-1265. [2] Shaw J, Shay B, Jiang J, et al. Metabolism studies of a smallmolecule tumor necrosis factoralpha (TNFα) inhibitor, UTL-5b (GBL-5b)[J]. Eur J Drug Metab Pharmacokinet, 2012, 37(2): 83-89. [3] 朱圣明, 宋仕茂, 吴峰, 等. 肿瘤坏死因子α对人喉鳞癌细胞放疗增敏作用的实验研究[J]. 重庆医学, 2010, 39(2): 133-136. [4] 熊晖, 孙宁, 袁健, 等. TNFa对鼻咽癌放射增敏的体内实验研究[J]. 湖北民族学院学报:医学版, 2010, 27(1): 9-13. [5] 夏晖, 于长海, 张宜明, 等. 肿瘤坏死因子α对人肺癌A549细胞的放疗增敏作用[J]. 南方医科大学学报, 2012, 32(4): 565-568. [6] 袁健, 孙宁, 王丽京, 等. 肿瘤坏死因子的细胞同步化作用对鼻咽癌放射敏感性的影响[J]. 南方医科大学学报, 2007, 27(3): 374-376. [7] Wang Y, Radfar S, Khong HT, et al. Activated CD4+ T cells enhance radiation effect through the cooperation of interferongamma and TNFalpha[J]. BMC Cancer, 2010, 10: 60. [8] Wang BF, Dai ZJ, Wang XJ, et al. Saikosaponind increases the radiosensitivity of smmc7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle[J]. BMC Complement Altern Med, 2013, 13: 263. [9] Anavi S, HahnObercyger M, Madar Z, et al. Mechanism for HIF1 activation by cholesterol under normoxia: a redox signaling pathway for liver damage[J]. Free Radic Biol Med, 2014, 71: 61-69. [10] Yang X, Yang B, Cai J, et al. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF1α in vitro and in vivo[J]. Cancer Biol Ther, 2013, 14(11): 1068-1073. [11] Nishida N, Yasui H, Nagane M, et al. 3Methyl pyruvate enhances radiosensitivity through increasing mitochondriaderived reactive oxygen species in tumor cell lines[J]. J Radiat Res, 2014, 55(3): 455-463. [12] Zhang Q, Zhang C, Yang X, et al. Berberine inhibits the expression of hypoxia induction factor1alpha and increases the radiosensitivity of prostate cancer[J]. Diagn Pathol, 2014, 9: 98. [13] 朱建红, 吴科锋, 吕应年. 谷胱甘肽与顺铂联用对肺癌A549细胞增殖的影响[J]. 广东医学院学报, 2013, 31(3): 260-263. [14] Qi R, Jin W, Wang J, et al. Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF1α expression[J]. Oncol Rep, 2014, 31(5): 2399-2406. [15] Ihara M, Takeshita S, Okaichi K, et al. Heat exposure enhances radiosensitivity by depressing DNAPK kinase activity during double strand break repair[J]. Int J Hyperthermia, 2014, 30(2): 102-109. [16] Rieckmann T, Tribius S, Grob TJ, et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity[J]. Radiother Oncol, 2013, 107(2): 242-246. [17] Martin NT, Nakamura K, Paila U, et al. Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA doublestrand breaks[J]. Cell Death Dis, 2014, 5: e1130. [18] Lin YF, Nagasawa H, Little JB, et al. Differential radiosensitivity phenotypes of DNAPKcs mutations affecting NHEJ and HRR systems following irradiation with gammarays or very low fluences of alpha particles[J]. PLoS One, 2014, 9(4): e93579. [19] Liu HT, Lu CL. Effect of silencing Bcl2 expression by small interfering RNA on radiosensitivity of gastric cancer BGC823 cells[J]. Asian Pac J Trop Med, 2013, 6(1): 49-52. [20] Zhu B, Yang LY, Zhao XK, et al. RNA interference of RelB enhances the radiosensitivity of prostate cancer cell line RM1 in mice[J]. Zhonghua Nan Ke Xue, 2012, 18(7): 595-599. [21] 张雁云, 张学光, 张毅, 等. 肿瘤坏死因子α对小鼠骨髓型放射损伤的防护作用[J]. 中华放射医学与防护杂志, 2000, 20(4): 257-260. [22] Meng Y, Mauceri HJ, Khodarev NN, et al. Ad.EgrTNF and local ionizing radiation suppress metastases by interferonbetadependent activation of antigenspecific CD8+ T cells[J]. Mol Ther, 2010, 18(5): 912-920. [23] Blling T, Kolkmeyer A, Greve B, et al. Heterogeneity of radiation and TNFalphainduced programmed cell death in carcinoma, sarcoma and lymphoma cell lines[J]. Anticancer Res, 2010, 30(7): 2857-2861. [24] Jung M, Dimtchev A, Velena A, et al. Combining radiation therapy with interstitial radiationinducible TNFα expression for locoregional cancer treatment[J]. Cancer Gene Ther, 2011, 18(3): 189-195. [25] Veeraraghavan J, Natarajan M, Aravindan S, et al. Radiationtriggered tumor necrosis factor (TNF) alphaNFkappaB crosssignaling favors survival advantage in human neuroblastoma cells[J]. J Biol Chem, 2011, 286(24): 1588-1600. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[4] | Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[5] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[6] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[7] | Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[8] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[9] | Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376. |
[10] | Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 version)[J]. Journal of International Oncology, 2023, 50(4): 193-201. |
[11] | Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230. |
[12] | Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247. |
[13] | Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases[J]. Journal of International Oncology, 2023, 50(3): 138-143. |
[14] | Huang Huayu, Gong Hongyun, Song Qibin.Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy[J]. Journal of International Oncology, 2023, 50(2): 102-106. |
[15] | Cao Xiaohui, Yu Hong, Li Wanhu.Application of CT-based radiomics analysis in predicting and identifying of treatment-associated pneumonitis[J]. Journal of International Oncology, 2023, 50(2): 107-111. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||